Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Clinical trial NCT03609398 · RECRUITING
Trial details
- NCT number
- NCT03609398
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2023-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.